TRENDING KEYWORDS
Clorox (CLX, $180.95) stock gets double-downgrade from Wells Fargo
Shares of Clorox fell Monday, following a double- downgrade by analysts at Wells Fargo.
Wells Fargo analysts lowered their rating on the consumer goods’ company’s shares to underweight from overweight. They also slashed price target to $170 a share from $240. Analyst Chris Carey called Clorox shares "dead money, at best, with downside."
According to Wells Fargo analysts, Clorox sales in the professional and international segments ( "new growth drivers") missed estimates – something that makes it hard to argue for 'underappreciated' upside, as indicated by the analysts.
CLX in upward trend: price may ascend as a result of having broken its lower Bollinger Band on May 19, 2022
CLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 20 of 33 cases where CLX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 61%.
Current price $146.44 crossed the support line at $143.11 and is trading between $159.34 support and $143.11 support lines. Throughout the month of 04/26/22 - 05/26/22, the price experienced a +0.09% Uptrend. During the week of 05/19/22 - 05/26/22, the stock enjoyed a +6% Uptrend growth.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CLX's RSI Oscillator exited the oversold zone, 13 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 54%.
The Stochastic Indicator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 32 of 63 cases where CLX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 51%.
CLX moved above its 50-day Moving Average on May 26, 2022 date and that indicates a change from a downward trend to an upward trend.
Following a +3.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLX advanced for three days, in 195 of 360 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
The Aroon Indicator entered an Uptrend today. In 151 of 276 cases where CLX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
The Momentum Indicator moved below the 0 level on May 18, 2022. You may want to consider selling the stock, shorting the stock, or exploring put options on CLX as a result. In 52 of 104 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 50%.
The Moving Average Convergence Divergence Histogram (MACD) for CLX turned negative on May 18, 2022. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 30 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 58%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
Tickeron has a negative outlook on this ticker and predicts a further decline by more than 4.00% within the next month with a likelihood of 82%. During the last month, the daily ratio of advancing to declining volumes was 1.35 to 1.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (45.045) is normal, around the industry mean (23.152). P/E Ratio (39.526) is within average values for comparable stocks, (175.479). CLX's Projected Growth (PEG Ratio) (6.583) is slightly higher than the industry average of (3.492). Dividend Yield (0.032) settles around the average of (0.026) among similar stocks. P/S Ratio (2.559) is also within normal values, averaging (61.519).
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating fairly steady price growth. CLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 68 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.
The average market capitalization across the Household/Personal Care Industry is 18.5B. The market cap for tickers in the group ranges from 84.3K to 348.4B. PG holds the highest valuation in this group at 348.4B. The lowest valued company is BMXC at 84.3K.
The average weekly price growth across all stocks in the Household/Personal Care Industry was 0.37%. For the same Industry, the average monthly price growth was -5.35%, and the average quarterly price growth was -17.52%. SNBH experienced the highest price growth at 45.71%, while LIOPY experienced the biggest fall at -56.44%.
- 5/19/22 8:25 AM: Clorox (CLX, $145.83) was a top loser this week, declining -5.83%
- 5/7/22 5:28 AM: Clorox (CLX, $153.94) was a top weekly gainer, with a +7.3% jump
- 5/3/22 8:19 AM: Clorox (CLX, $143.28) was a top loser this week, declining -5.19%
The average weekly volume growth across all stocks in the Household/Personal Care Industry was -15.44%. For the same stocks of the Industry, the average monthly volume growth was -26.25% and the average quarterly volume growth was 4.44%
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Stocks in the group have a Negative Outlook today, backed by the MA200MA50 Indicator. Tickeron has a negative outlook on this group and predicts a further decline by more than 4.00% within the next month with a likelihood of 37%. During the last month, the daily ratio of advancing to declining volumes was 1 to 1.22.
9 stocks in the group of tickers exhibit a similar negative trend based on the 15 indicator with an average likelihood of 64%.
The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).
The average market capitalization across the group is 21B. The market cap for tickers in the group ranges from 168.4K to 348.4B. PG holds the highest valuation in this group at 348.4B. The lowest valued company is QTCI at 168.4K.
The average weekly price growth across all stocks in the group was 0.02%. For the same group, the average monthly price growth was -4.86%, and the average quarterly price growth was -15.46%. HYPMY experienced the highest price growth at 18.15%, while EACTF experienced the biggest fall at -66.75%.
- 5/21/22 6:31 AM: Energizer Holdings (ENR, $31.11) was a top loser this week, declining -6.49%
- 5/20/22 5:28 AM: Kimberly-Clark (KMB, $129.05) was a top loser this week, declining -7.56%
- 5/19/22 8:25 AM: Clorox (CLX, $145.83) was a top loser this week, declining -5.83%
The average weekly volume growth across all stocks in the group was 38.87%. For the same stocks of the group, the average monthly volume growth was 810.88% and the average quarterly volume growth was 332.55%
- 4/30/22 5:53 AM: The volume for NuSkin Enterprises stock increased for one day, resulting in a record-breaking daily growth of 433% of the 65-Day Volume Moving Average
- 3/26/22 5:58 AM: The volume for Jupiter Wellness stock increased for one day, resulting in a record-breaking daily growth of 313% of the 65-Day Volume Moving Average
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Latest blogs by Sarah Patel
Top Blogs
